NewsBytes
    Hindi Tamil Telugu
    More
    In the news
    Supreme Court Of India
    Central Bureau Of Investigation (CBI)
    Indian Army
    Indian Railways
    Indian Air Force
    NewsBytes
    Hindi Tamil Telugu
    NewsBytes
    User Placeholder

    Hi,

    Logout


    India Business World Politics Sports Technology Entertainment Auto Lifestyle Inspirational Career Bengaluru Delhi Mumbai Visual Stories Find Cricket Statistics Phones Reviews Fitness Bands Reviews Speakers Reviews

    Download Android App

    Follow us on
    • Facebook
    • Twitter
    • Linkedin
     
    Home / News / India News / Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension
    India

    Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension

    Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension
    Written by Abhishek Hari
    Apr 29, 2022, 10:32 pm 2 min read
    Centre denies asking Bharat Biotech to address WHO's COVAXIN suspension
    The WHO said it had halted the supply of COVAXIN to UN agencies due to recent GMP (good manufacturing practice) deficiencies.

    The Ministry of External Affairs (MEA) on Friday denied reports that it had asked Bharat Biotech to address issues to avoid the cancellation of the World Health Organization's (WHO) emergency approval for its COVAXIN. The MEA said that "selective parts" of its "communication have been highlighted out of context to portray an incorrect picture."

    Why does this story matter?

    • The WHO announced on April 2 that it had decided to cancel the supply of COVAXIN via UN agencies in order to enable Bharat Biotech to address deficiencies in manufacturing practices discovered during an inspection.
    • The WHO, however, stated the vaccine was effective and safe, adding there was no "change in the risk-benefit ratio," but advised countries that received COVAXIN to "take appropriate actions."

    It's an internal document, doesn't indicate MEA position: Sources

    Reports claiming the MEA's alleged communication to Bharat Biotech referred "to an internal document circulated to members of the [Centre's] Empowered Group-5, which comprehensively looks at all issues related to vaccines," sources told ANI. They added the note only enlists different problems in a factual manner for the Empowered Group's consideration but doesn't indicate the MEA's stance or remark on any issue under review.

    What did the media reports say?

    Recent reports cited an alleged MEA communication between Foreign Secretary Harsh Vardhan Shringla and the Empowered Group. Shringla said issues concerning vaccines used in the country and Indians' international travel have arisen, including the WHO's suspension of COVAXIN supplies and m-RNA-based booster requirements by several countries. He suggested Bharat Biotech address issues raised by the WHO to avoid the cancellation of COVAXIN's emergency approval.

    What is so controversial about the communication?

    The issue has become controversial as reports quoted Shringla as saying, "Bharat Biotech must address the matter immediately through DCGI and WHO and avoid any situation that may lead to cancellation of WHO's EUL (Emergency Use Listing) for COVAXIN." Notably, the MEA had also clarified earlier that the WHO's supply suspension will not affect travelers who had received the Bharat Biotech-manufactured COVID-19 vaccine.

    COVAXIN cleared for kids in 6-12 age group

    Meanwhile, the Drugs Controller General of India (DCGI) on Tuesday granted further emergency use authorization to Bharat Biotech's COVAXIN for administration to kids in the 6-12 years age group and Biological E's Corbevax for the 5-12 age group as COVID-19 cases gradually rise in India.

    Share this timeline
    Facebook
    Whatsapp
    Twitter
    Linkedin
    World Health Organization
    Ministry Of External Affairs
    COVID-19
    Bharat Biotech

    World Health Organization

    China reports first human case of H3N8 bird flu China
    WHO's first global traditional medicine center in Gujarat by 2024 Gujarat
    Not 5L, 40L Indians died of COVID-19, claims Rahul Gandhi India
    India questions WHO's methodology to calculate COVID-19 deaths: Here's why Union Ministry of Health and Family Welfare

    Ministry Of External Affairs

    Toronto: Indian student shot dead, family alleges no government assistance Canada
    China's comments on J&K in Pakistan 'uncalled for,' says India India
    Canada: Five Indian students killed, two injured in road-accident Canada
    Ukraine: India denies claims that citizens in Kharkiv are held "hostages" India

    COVID-19

    China: Shanghai eases COVID-19 restrictions as cases decline Beijing
    COVID-19: India reports 3,377 new cases, 60 more deaths COVID-19 India
    COVID-19: India logs 3,303 new cases; 39 more deaths Coronavirus
    Kerala makes wearing face masks mandatory amid rising COVID-19 cases Kerala

    Bharat Biotech

    COVAXIN likely to get approval for children above 2yrs: Report Drugs Controller General of India
    COVAXIN supply to be increased as teens get COVID-19 vaccines COVID-19
    Are Indian vaccines effective against Omicron? Here's what manufacturers say Zydus Cadila
    COVAXIN gets WHO approval for emergency use listing World Health Organization

    Love India News?

    Subscribe to stay updated.

    India Thumbnail
    Indian Premier League (IPL) Celebrity Hollywood Bollywood UEFA Champions League Tennis Football Smartphones Cryptocurrency Upcoming Movies Premier League Cricket News Latest automobiles Latest Cars Upcoming Cars Latest Bikes Upcoming Tablets
    About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive Download DevBytes Find Cricket Statistics
    Follow us on
    Facebook Twitter Linkedin
    All rights reserved © NewsBytes 2023